These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 22195536)

  • 1. Safety of iodinated intravenous contrast medium administration in sickle cell disease.
    Campbell KL; Hud LM; Adams S; Andrel J; Ballas SK; Feldman AM; Axelrod D
    Am J Med; 2012 Jan; 125(1):100.e11-6. PubMed ID: 22195536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast medium-induced acute kidney injury: comparison of intravenous and intraarterial administration of iodinated contrast medium.
    Karlsberg RP; Dohad SY; Sheng R;
    J Vasc Interv Radiol; 2011 Aug; 22(8):1159-65. PubMed ID: 21570871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of iodixanol and iohexol in patients undergoing intravenous pyelography: a prospective controlled study.
    Chuang FR; Chen TC; Wang IK; Chuang CH; Chang HW; Ting-Yu Chiou T; Cheng YF; Lee WC; Chen WC; Yang KD; Lee CH
    Ren Fail; 2009; 31(3):181-8. PubMed ID: 19288321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iso-osmolar radio contrast iodixanol in patients with chronic kidney disease.
    Tadros GM; Malik JA; Manske CL; Kasiske BL; Dickinson SE; Herzog CA; Wilson RF; Das G; Panetta CJ
    J Invasive Cardiol; 2005 Apr; 17(4):211-5. PubMed ID: 15831975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intravenous low-osmolality iodinated contrast media on patients with myasthenia gravis.
    Somashekar DK; Davenport MS; Cohan RH; Dillman JR; Ellis JH
    Radiology; 2013 Jun; 267(3):727-34. PubMed ID: 23360741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effects of radiographic contrast media on dehydration and filterability of red blood cells from donors homozygous for hemoglobin A or hemoglobin S.
    Losco P; Nash G; Stone P; Ventre J
    Am J Hematol; 2001 Nov; 68(3):149-58. PubMed ID: 11754395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between gadolinium and iodine contrast for percutaneous intervention in atherosclerotic renal artery stenosis: clinical outcomes.
    Kane GC; Stanson AW; Kalnicka D; Rosenthal DW; Lee CU; Textor SC; Garovic VD
    Nephrol Dial Transplant; 2008 Apr; 23(4):1233-40. PubMed ID: 18256017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of non-ionic iodinated contrast media on patient heart rate and pressures during intra-cardiac or intra-arterial injection.
    Schmid I; Didier D; Pfammatter T; Garachemani A; Fleisch M; Kirchin MA; Meier B
    Int J Cardiol; 2007 Jun; 118(3):389-96. PubMed ID: 17376548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adverse reactions to contrast media for intravenous use. A comparison between ionic and nonionic media].
    Urrutia M; Macharaviaya A; Rodríguez R
    Rev Med Panama; 1995; 20(1-2):20-4. PubMed ID: 7480899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High incidence of nephropathy in neurosurgical patients after intra-arterial administration of low-osmolar and iso-osmolar contrast media.
    Serafin Z; Karolkiewicz M; Gruszka M; Strózecki P; Lasek W; Odrowaz-Sypniewska G; Manitius J; Beuth W
    Acta Radiol; 2011 May; 52(4):422-9. PubMed ID: 21498279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal safety of iodixanol.
    McCullough PA
    Expert Rev Cardiovasc Ther; 2006 Sep; 4(5):655-61. PubMed ID: 17081087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iso-osmolality versus low-osmolality iodinated contrast medium at intravenous contrast-enhanced CT: effect on kidney function.
    Nguyen SA; Suranyi P; Ravenel JG; Randall PK; Romano PB; Strom KA; Costello P; Schoepf UJ
    Radiology; 2008 Jul; 248(1):97-105. PubMed ID: 18483232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the Contrast Media and Nephrotoxicity Following Primary Angioplasty for Acute Myocardial Infarction [CONTRAST-AMI] Trial).
    Bolognese L; Falsini G; Schwenke C; Grotti S; Limbruno U; Liistro F; Carrera A; Angioli P; Picchi A; Ducci K; Pierli C
    Am J Cardiol; 2012 Jan; 109(1):67-74. PubMed ID: 21943940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iodixanol: risk of subsequent contrast nephropathy in cancer patients with underlying renal insufficiency undergoing diagnostic computed tomography examinations.
    Cheruvu B; Henning K; Mulligan J; Klippenstein D; Lawrence D; Gurtoo L; Gottlieb RH
    J Comput Assist Tomogr; 2007; 31(4):493-8. PubMed ID: 17882021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal Insufficiency Following Radiocontrast Exposure Trial (REINFORCE): a randomized comparison of sodium bicarbonate versus sodium chloride hydration for the prevention of contrast-induced nephropathy.
    Adolph E; Holdt-Lehmann B; Chatterjee T; Paschka S; Prott A; Schneider H; Koerber T; Ince H; Steiner M; Schuff-Werner P; Nienaber CA
    Coron Artery Dis; 2008 Sep; 19(6):413-9. PubMed ID: 18955835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iodinated contrast media and contrast-induced nephropathy: is there a preferred cost-effective agent?
    Sharma SK
    J Invasive Cardiol; 2008 May; 20(5):245-8. PubMed ID: 18460711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-marketing surveillance of the safety profile of iodixanol in the outpatient CT setting: a prospective, multicenter, observational study of patient risk factors, adverse reactions and preventive measures in 9953 patients.
    Müller FH
    Rofo; 2014 Nov; 186(11):1028-34. PubMed ID: 24729407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies.
    Briguori C; Airoldi F; D'Andrea D; Bonizzoni E; Morici N; Focaccio A; Michev I; Montorfano M; Carlino M; Cosgrave J; Ricciardelli B; Colombo A
    Circulation; 2007 Mar; 115(10):1211-7. PubMed ID: 17309916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study.
    Mehran R; Nikolsky E; Kirtane AJ; Caixeta A; Wong SC; Teirstein PS; Downey WE; Batchelor WB; Casterella PJ; Kim YH; Fahy M; Dangas GD
    JACC Cardiovasc Interv; 2009 May; 2(5):415-21. PubMed ID: 19463464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and toleration of the non-ionic contrast medium iopentol. An intravenous phase I trial.
    Jakobsen JA; Hagve TA; Holager T; Waaler A; Haider T; Andrew E; Aakhus T
    Eur J Radiol; 1989 Nov; 9(4):203-7. PubMed ID: 2591384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.